Humacyte, Inc. (HUMA)
(Delayed Data from NSDQ)
$5.48 USD
+0.78 (16.60%)
Updated May 13, 2024 04:00 PM ET
After-Market: $5.80 +0.32 (5.84%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Brokerage Reports
Humacyte, Inc. [HUMA]
Reports for Purchase
Showing records 1 - 3 ( 3 total )
Company: Humacyte, Inc.
Industry: Unclassified
We HAVe a BLA Now; FDA Application Submitted; Reiterate Buy and $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Humacyte, Inc.
Industry: Unclassified
We Could HAVe a New Alternative for Treating Vascular Injury Soon; Initiating at Buy With a $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Humacyte, Inc.
Industry: Unclassified
|